APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rare Disease Therapy Solutions

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Rare Disease Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 January 2026199 pages

Choose your research edition.

Industry ResearchRare Disease Therapy Solutions Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Disease Therapy Solutions Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Rare Disease Therapy Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Disease Therapy Solutions Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rare Disease Therapy Solutions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Rare Disease Therapy Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Rare Disease Therapy Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rare Disease Therapy Solutions include Sarepta, Ultragenyx, Amicus Therapeutics, AOP Health, Fortrea, Chiesi Global Rare Diseases, Travere Therapeutics, Sobi and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Rare Disease Therapy Solutions market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rare Disease Therapy Solutions and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rare Disease Therapy Solutions revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Rare Disease Therapy Solutions market size, projected growth trends, production technologies, key applications, and end-use industries.

Rare Disease Therapy Solutions Segment by Company

Sarepta

Ultragenyx

Amicus Therapeutics

AOP Health

Fortrea

Chiesi Global Rare Diseases

Travere Therapeutics

Sobi

Novartis

Vertex Pharmaceuticals

Sarepta International UK Ltd.

Orsini

Roche

Certara

Sciensus

Rare Disease Therapy Solutions Segment by Type

Gene Therapy

Enzyme Replacement Therapy

Small Molecule Targeted Drugs

Cell Therapy

Others

Rare Disease Therapy Solutions Segment by Application

Metabolic Diseases

Hematological Diseases

Others

Rare Disease Therapy Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Disease Therapy Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Disease Therapy Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Disease Therapy Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Rare Disease Therapy Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rare Disease Therapy Solutions industry.

Chapter 3: Detailed analysis of Rare Disease Therapy Solutions companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rare Disease Therapy Solutionsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rare Disease Therapy Solutions Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Gene Therapy Table 3. Key Players of Enzyme Replacement Therapy Table 4. Key Players of Small Molecule Targeted Drugs Table 3. Key Players of Cell Therapy Table 4. Key Players of Others Table 5. Global Rare Disease Therapy Solutions Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Metabolic Diseases Table 7. Key Players of Hematological Diseases Table 8. Key Players of Others Table 9. Global Rare Disease Therapy Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Rare Disease Therapy Solutions Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Rare Disease Therapy Solutions Market Share by Region (2021-2026) Table 12. Global Rare Disease Therapy Solutions Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Rare Disease Therapy Solutions Market Share by Region (2027-2032) Table 14. Rare Disease Therapy Solutions Industry Trends Table 15. Rare Disease Therapy Solutions Industry Drivers Table 16. Rare Disease Therapy Solutions Industry Opportunities and Challenges Table 17. Rare Disease Therapy Solutions Industry Restraints Table 18. Global Rare Disease Therapy Solutions Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Rare Disease Therapy Solutions Revenue Market Share by Company (2021-2026) Table 20. Global Rare Disease Therapy Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Rare Disease Therapy Solutions Key Company Head Office and Area Served Table 22. Global Rare Disease Therapy Solutions Company, Product Type & Application Table 23. Global Rare Disease Therapy Solutions Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Rare Disease Therapy Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Rare Disease Therapy Solutions Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Rare Disease Therapy Solutions Revenue Market Share by Type (2021-2026) Table 30. Global Rare Disease Therapy Solutions Revenue Market Share by Type (2027-2032) Table 31. Global Rare Disease Therapy Solutions Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Rare Disease Therapy Solutions Revenue Market Share by Application (2021-2026) Table 35. Global Rare Disease Therapy Solutions Revenue Market Share by Application (2027-2032) Table 36. Sarepta Company Information Table 37. Sarepta Business Overview Table 38. Sarepta Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Sarepta Rare Disease Therapy Solutions Product Portfolio Table 40. Sarepta Recent Development Table 41. Ultragenyx Company Information Table 42. Ultragenyx Business Overview Table 43. Ultragenyx Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Ultragenyx Rare Disease Therapy Solutions Product Portfolio Table 45. Ultragenyx Recent Development Table 46. Amicus Therapeutics Company Information Table 47. Amicus Therapeutics Business Overview Table 48. Amicus Therapeutics Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Amicus Therapeutics Rare Disease Therapy Solutions Product Portfolio Table 50. Amicus Therapeutics Recent Development Table 51. AOP Health Company Information Table 52. AOP Health Business Overview Table 53. AOP Health Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AOP Health Rare Disease Therapy Solutions Product Portfolio Table 55. AOP Health Recent Development Table 56. Fortrea Company Information Table 57. Fortrea Business Overview Table 58. Fortrea Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Fortrea Rare Disease Therapy Solutions Product Portfolio Table 60. Fortrea Recent Development Table 61. Chiesi Global Rare Diseases Company Information Table 62. Chiesi Global Rare Diseases Business Overview Table 63. Chiesi Global Rare Diseases Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Chiesi Global Rare Diseases Rare Disease Therapy Solutions Product Portfolio Table 65. Chiesi Global Rare Diseases Recent Development Table 66. Travere Therapeutics Company Information Table 67. Travere Therapeutics Business Overview Table 68. Travere Therapeutics Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Travere Therapeutics Rare Disease Therapy Solutions Product Portfolio Table 70. Travere Therapeutics Recent Development Table 71. Sobi Company Information Table 72. Sobi Business Overview Table 73. Sobi Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Sobi Rare Disease Therapy Solutions Product Portfolio Table 75. Sobi Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Novartis Rare Disease Therapy Solutions Product Portfolio Table 80. Novartis Recent Development Table 81. Vertex Pharmaceuticals Company Information Table 82. Vertex Pharmaceuticals Business Overview Table 83. Vertex Pharmaceuticals Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Vertex Pharmaceuticals Rare Disease Therapy Solutions Product Portfolio Table 85. Vertex Pharmaceuticals Recent Development Table 86. Sarepta International UK Ltd. Company Information Table 87. Sarepta International UK Ltd. Business Overview Table 88. Sarepta International UK Ltd. Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sarepta International UK Ltd. Rare Disease Therapy Solutions Product Portfolio Table 90. Sarepta International UK Ltd. Recent Development Table 91. Orsini Company Information Table 92. Orsini Business Overview Table 93. Orsini Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Orsini Rare Disease Therapy Solutions Product Portfolio Table 95. Orsini Recent Development Table 96. Roche Company Information Table 97. Roche Business Overview Table 98. Roche Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Roche Rare Disease Therapy Solutions Product Portfolio Table 100. Roche Recent Development Table 101. Certara Company Information Table 102. Certara Business Overview Table 103. Certara Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Certara Rare Disease Therapy Solutions Product Portfolio Table 105. Certara Recent Development Table 106. Sciensus Company Information Table 107. Sciensus Business Overview Table 108. Sciensus Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Sciensus Rare Disease Therapy Solutions Product Portfolio Table 110. Sciensus Recent Development Table 111. North America Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 112. North America Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 113. North America Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 114. North America Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 115. North America Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Rare Disease Therapy Solutions Market Size by Country (2021-2026) Table 117. North America Rare Disease Therapy Solutions Market Size by Country (2027-2032) Table 118. Europe Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 119. Europe Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 120. Europe Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 121. Europe Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 122. Europe Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Rare Disease Therapy Solutions Market Size by Country (2021-2026) Table 124. Europe Rare Disease Therapy Solutions Market Size by Country (2027-2032) Table 125. China Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 126. China Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 127. China Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 128. China Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 129. Asia Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 130. Asia Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 131. Asia Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 132. Asia Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 133. Asia Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Rare Disease Therapy Solutions Market Size by Country (2021-2026) Table 135. Asia Rare Disease Therapy Solutions Market Size by Country (2027-2032) Table 136. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Type (2021-2026) & (US$ Million) Table 137. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Type (2027-2032) & (US$ Million) Table 138. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Application (2021-2026) & (US$ Million) Table 139. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Application (2027-2032) & (US$ Million) Table 140. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021-2026) Table 142. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Rare Disease Therapy Solutions Product Image Figure 2. Global Rare Disease Therapy Solutions Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Rare Disease Therapy Solutions Market Share by Type: 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Enzyme Replacement Therapy Image Figure 6. Small Molecule Targeted Drugs Image Figure 7. Cell Therapy Image Figure 8. Others Image Figure 9. Global Rare Disease Therapy Solutions Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Rare Disease Therapy Solutions Market Share by Application: 2025 VS 2032 Figure 11. Metabolic Diseases Image Figure 12. Hematological Diseases Image Figure 13. Others Image Figure 14. Global Rare Disease Therapy Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 16. Global Rare Disease Therapy Solutions Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Rare Disease Therapy Solutions Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Rare Disease Therapy Solutions Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Rare Disease Therapy Solutions Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Rare Disease Therapy Solutions Revenue Market Share by Type (2021-2032) Figure 23. Global Rare Disease Therapy Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rare Disease Therapy Solutions Revenue Market Share by Application (2021-2032) Figure 25. North America Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 26. North America Rare Disease Therapy Solutions Market Share by Type (2021-2032) Figure 27. North America Rare Disease Therapy Solutions Market Share by Application (2021-2032) Figure 28. North America Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 29. United States Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 30. Canada Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 32. Europe Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 33. Europe Rare Disease Therapy Solutions Market Share by Type (2021-2032) Figure 34. Europe Rare Disease Therapy Solutions Market Share by Application (2021-2032) Figure 35. Europe Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 36. Germany Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 37. France Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 39. Italy Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 40. Russia Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 42. China Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 43. China Rare Disease Therapy Solutions Market Share by Type (2021-2032) Figure 44. China Rare Disease Therapy Solutions Market Share by Application (2021-2032) Figure 45. Asia Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 46. Asia Rare Disease Therapy Solutions Market Share by Type (2021-2032) Figure 47. Asia Rare Disease Therapy Solutions Market Share by Application (2021-2032) Figure 48. Asia Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 49. Japan Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 53. India Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 54. Australia Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Country (2021-2032) Figure 59. Brazil Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 64. UAE Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 66. Chile Rare Disease Therapy Solutions Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Enzyme Replacement Therapy
  • Small Molecule Targeted Drugs
  • Cell Therapy
  • Others
Applications
  • Metabolic Diseases
  • Hematological Diseases
  • Others
Companies covered
  • Sarepta
  • Ultragenyx
  • Amicus Therapeutics
  • AOP Health
  • Fortrea
  • Chiesi Global Rare Diseases
  • Travere Therapeutics
  • Sobi
  • Novartis
  • Vertex Pharmaceuticals
  • Sarepta International UK Ltd.
  • Orsini
  • Roche
  • Certara
  • Sciensus

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Rare Disease Therapy Solutions Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Enzyme Replacement Therapy
  6. 1.2.4 Small Molecule Targeted Drugs
  7. 1.2.5 Cell Therapy
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Rare Disease Therapy Solutions Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Metabolic Diseases
  12. 1.3.3 Hematological Diseases
  13. 1.3.4 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Rare Disease Therapy Solutions Growth Trends by Region
  16. 1.5.1 Global Rare Disease Therapy Solutions Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Rare Disease Therapy Solutions Market Size by Region (2021-2026)
  18. 1.5.3 Rare Disease Therapy Solutions Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Rare Disease Therapy Solutions Market Dynamics
  1. 2.1 Rare Disease Therapy Solutions Industry Trends
  2. 2.2 Rare Disease Therapy Solutions Industry Drivers
  3. 2.3 Rare Disease Therapy Solutions Industry Opportunities and Challenges
  4. 2.4 Rare Disease Therapy Solutions Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Rare Disease Therapy Solutions Revenue by Company (2021-2026)
  2. 3.2 Global Rare Disease Therapy Solutions Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Rare Disease Therapy Solutions Key Company Head office and Area Served
  4. 3.4 Global Rare Disease Therapy Solutions Company, Product Type & Application
  5. 3.5 Global Rare Disease Therapy Solutions Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Rare Disease Therapy Solutions Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Rare Disease Therapy Solutions Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Rare Disease Therapy Solutions Tier 1, Tier 2, and Tier 3
4 Rare Disease Therapy Solutions Market by Type
  1. 4.1 Global Rare Disease Therapy Solutions Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Rare Disease Therapy Solutions Market Size by Type (2021-2032)
  3. 4.3 Global Rare Disease Therapy Solutions Market Size Share by Type (2021-2032)
5 Rare Disease Therapy Solutions Market by Application
  1. 5.1 Global Rare Disease Therapy Solutions Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Rare Disease Therapy Solutions Market Size by Application (2021-2032)
  3. 5.3 Global Rare Disease Therapy Solutions Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sarepta
  2. 6.1.1 Sarepta Company Information
  3. 6.1.2 Sarepta Business Overview
  4. 6.1.3 Sarepta Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sarepta Rare Disease Therapy Solutions Product Portfolio
  6. 6.1.5 Sarepta Recent Developments
  7. 6.2 Ultragenyx
  8. 6.2.1 Ultragenyx Company Information
  9. 6.2.2 Ultragenyx Business Overview
  10. 6.2.3 Ultragenyx Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ultragenyx Rare Disease Therapy Solutions Product Portfolio
  12. 6.2.5 Ultragenyx Recent Developments
  13. 6.3 Amicus Therapeutics
  14. 6.3.1 Amicus Therapeutics Company Information
  15. 6.3.2 Amicus Therapeutics Business Overview
  16. 6.3.3 Amicus Therapeutics Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amicus Therapeutics Rare Disease Therapy Solutions Product Portfolio
  18. 6.3.5 Amicus Therapeutics Recent Developments
  19. 6.4 AOP Health
  20. 6.4.1 AOP Health Company Information
  21. 6.4.2 AOP Health Business Overview
  22. 6.4.3 AOP Health Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AOP Health Rare Disease Therapy Solutions Product Portfolio
  24. 6.4.5 AOP Health Recent Developments
  25. 6.5 Fortrea
  26. 6.5.1 Fortrea Company Information
  27. 6.5.2 Fortrea Business Overview
  28. 6.5.3 Fortrea Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fortrea Rare Disease Therapy Solutions Product Portfolio
  30. 6.5.5 Fortrea Recent Developments
  31. 6.6 Chiesi Global Rare Diseases
  32. 6.6.1 Chiesi Global Rare Diseases Company Information
  33. 6.6.2 Chiesi Global Rare Diseases Business Overview
  34. 6.6.3 Chiesi Global Rare Diseases Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Chiesi Global Rare Diseases Rare Disease Therapy Solutions Product Portfolio
  36. 6.6.5 Chiesi Global Rare Diseases Recent Developments
  37. 6.7 Travere Therapeutics
  38. 6.7.1 Travere Therapeutics Company Information
  39. 6.7.2 Travere Therapeutics Business Overview
  40. 6.7.3 Travere Therapeutics Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Travere Therapeutics Rare Disease Therapy Solutions Product Portfolio
  42. 6.7.5 Travere Therapeutics Recent Developments
  43. 6.8 Sobi
  44. 6.8.1 Sobi Company Information
  45. 6.8.2 Sobi Business Overview
  46. 6.8.3 Sobi Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Sobi Rare Disease Therapy Solutions Product Portfolio
  48. 6.8.5 Sobi Recent Developments
  49. 6.9 Novartis
  50. 6.9.1 Novartis Company Information
  51. 6.9.2 Novartis Business Overview
  52. 6.9.3 Novartis Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novartis Rare Disease Therapy Solutions Product Portfolio
  54. 6.9.5 Novartis Recent Developments
  55. 6.10 Vertex Pharmaceuticals
  56. 6.10.1 Vertex Pharmaceuticals Company Information
  57. 6.10.2 Vertex Pharmaceuticals Business Overview
  58. 6.10.3 Vertex Pharmaceuticals Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Vertex Pharmaceuticals Rare Disease Therapy Solutions Product Portfolio
  60. 6.10.5 Vertex Pharmaceuticals Recent Developments
  61. 6.11 Sarepta International UK Ltd.
  62. 6.11.1 Sarepta International UK Ltd. Company Information
  63. 6.11.2 Sarepta International UK Ltd. Business Overview
  64. 6.11.3 Sarepta International UK Ltd. Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sarepta International UK Ltd. Rare Disease Therapy Solutions Product Portfolio
  66. 6.11.5 Sarepta International UK Ltd. Recent Developments
  67. 6.12 Orsini
  68. 6.12.1 Orsini Company Information
  69. 6.12.2 Orsini Business Overview
  70. 6.12.3 Orsini Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Orsini Rare Disease Therapy Solutions Product Portfolio
  72. 6.12.5 Orsini Recent Developments
  73. 6.13 Roche
  74. 6.13.1 Roche Company Information
  75. 6.13.2 Roche Business Overview
  76. 6.13.3 Roche Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Roche Rare Disease Therapy Solutions Product Portfolio
  78. 6.13.5 Roche Recent Developments
  79. 6.14 Certara
  80. 6.14.1 Certara Company Information
  81. 6.14.2 Certara Business Overview
  82. 6.14.3 Certara Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Certara Rare Disease Therapy Solutions Product Portfolio
  84. 6.14.5 Certara Recent Developments
  85. 6.15 Sciensus
  86. 6.15.1 Sciensus Company Information
  87. 6.15.2 Sciensus Business Overview
  88. 6.15.3 Sciensus Rare Disease Therapy Solutions Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Sciensus Rare Disease Therapy Solutions Product Portfolio
  90. 6.15.5 Sciensus Recent Developments
7 North America
  1. 7.1 North America Rare Disease Therapy Solutions Market Size (2021-2032)
  2. 7.2 North America Rare Disease Therapy Solutions Market Size by Type
  3. 7.2.1 North America Rare Disease Therapy Solutions Market Size by Type (2021-2026)
  4. 7.2.2 North America Rare Disease Therapy Solutions Market Size by Type (2027-2032)
  5. 7.2.3 North America Rare Disease Therapy Solutions Market Share by Type (2021-2032)
  6. 7.3 North America Rare Disease Therapy Solutions Market Size by Application
  7. 7.3.1 North America Rare Disease Therapy Solutions Market Size by Application (2021-2026)
  8. 7.3.2 North America Rare Disease Therapy Solutions Market Size by Application (2027-2032)
  9. 7.3.3 North America Rare Disease Therapy Solutions Market Share by Application (2021-2032)
  10. 7.4 North America Rare Disease Therapy Solutions Market Size by Country
  11. 7.4.1 North America Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  13. 7.4.3 North America Rare Disease Therapy Solutions Market Size by Country (2027-2032)
  14. 7.4.4 North America Rare Disease Therapy Solutions Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Rare Disease Therapy Solutions Market Size (2021-2032)
  2. 8.2 Europe Rare Disease Therapy Solutions Market Size by Type
  3. 8.2.1 Europe Rare Disease Therapy Solutions Market Size by Type (2021-2026)
  4. 8.2.2 Europe Rare Disease Therapy Solutions Market Size by Type (2027-2032)
  5. 8.2.3 Europe Rare Disease Therapy Solutions Market Share by Type (2021-2032)
  6. 8.3 Europe Rare Disease Therapy Solutions Market Size by Application
  7. 8.3.1 Europe Rare Disease Therapy Solutions Market Size by Application (2021-2026)
  8. 8.3.2 Europe Rare Disease Therapy Solutions Market Size by Application (2027-2032)
  9. 8.3.3 Europe Rare Disease Therapy Solutions Market Share by Application (2021-2032)
  10. 8.4 Europe Rare Disease Therapy Solutions Market Size by Country
  11. 8.4.1 Europe Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  13. 8.4.3 Europe Rare Disease Therapy Solutions Market Size by Country (2027-2032)
  14. 8.4.4 Europe Rare Disease Therapy Solutions Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Rare Disease Therapy Solutions Market Size (2021-2032)
  2. 9.2 China Rare Disease Therapy Solutions Market Size by Type
  3. 9.2.1 China Rare Disease Therapy Solutions Market Size by Type (2021-2026)
  4. 9.2.2 China Rare Disease Therapy Solutions Market Size by Type (2027-2032)
  5. 9.2.3 China Rare Disease Therapy Solutions Market Share by Type (2021-2032)
  6. 9.3 China Rare Disease Therapy Solutions Market Size by Application
  7. 9.3.1 China Rare Disease Therapy Solutions Market Size by Application (2021-2026)
  8. 9.3.2 China Rare Disease Therapy Solutions Market Size by Application (2027-2032)
  9. 9.3.3 China Rare Disease Therapy Solutions Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Rare Disease Therapy Solutions Market Size (2021-2032)
  2. 10.2 Asia Rare Disease Therapy Solutions Market Size by Type
  3. 10.2.1 Asia Rare Disease Therapy Solutions Market Size by Type (2021-2026)
  4. 10.2.2 Asia Rare Disease Therapy Solutions Market Size by Type (2027-2032)
  5. 10.2.3 Asia Rare Disease Therapy Solutions Market Share by Type (2021-2032)
  6. 10.3 Asia Rare Disease Therapy Solutions Market Size by Application
  7. 10.3.1 Asia Rare Disease Therapy Solutions Market Size by Application (2021-2026)
  8. 10.3.2 Asia Rare Disease Therapy Solutions Market Size by Application (2027-2032)
  9. 10.3.3 Asia Rare Disease Therapy Solutions Market Share by Application (2021-2032)
  10. 10.4 Asia Rare Disease Therapy Solutions Market Size by Country
  11. 10.4.1 Asia Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  13. 10.4.3 Asia Rare Disease Therapy Solutions Market Size by Country (2027-2032)
  14. 10.4.4 Asia Rare Disease Therapy Solutions Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Rare Disease Therapy Solutions Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Rare Disease Therapy Solutions Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst